Educators are now a priority for COVID-19 vaccinations, with plans to have all people who work…
Author: admin
NeuroBo Pharmaceuticals to Participate in H.C. Wainwright Global Life Sciences Conference
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced that Company management will participate in the…
FDA Authorizes Cue Health’s COVID-19 Test for At-Home and Over The Counter Use
Cue Health Inc. (Cue) announced the healthcare technology company has received Emergency Use Authorization (EUA) from the…
Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical’s Razuprotafib in I-SPY COVID Trial
Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with…
Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the T-Detect…
Sartorius is a corporate partner of the Healthcare Businesswomen’s Association
The life science group Sartorius has joined the Healthcare Businesswomen’s Association (HBA) as a corporate partner.…
Agilent to buy NGS-based precision oncology solutions company, Resolution Bioscience for 550 million
Agilent Technologies Inc., announced it has entered into a definitive agreement to acquire Resolution Bioscience Inc.,…
Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants
Seegene (KQ096530), a biotechnology company specializing in molecular diagnostics, said Wednesday it finished the development of the…
Proxalutamide Phase III Clinical Trial for the Treatment of COVID-19 Patients Approved by FDA
Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the Investigational New Drug (IND) application…
Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd®
he upcoming Phase III trial with Diamyd® in new-onset type 1 diabetes will be based on the…